Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Clover Health Investments, Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$4.00 |
52 Week High | US$4.71 |
52 Week Low | US$0.61 |
Beta | 2.14 |
11 Month Change | 33.33% |
3 Month Change | 145.40% |
1 Year Change | 304.45% |
33 Year Change | -46.67% |
5 Year Change | n/a |
Change since IPO | -60.78% |
Recent News & Updates
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03Clover Health: Changing Business Model, Seeking Profitability
Oct 03Recent updates
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03Clover Health: Changing Business Model, Seeking Profitability
Oct 03Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Shareholder Returns
CLOV | US Healthcare | US Market | |
---|---|---|---|
7D | -1.7% | -3.2% | 1.1% |
1Y | 304.4% | 4.0% | 36.0% |
Return vs Industry: CLOV exceeded the US Healthcare industry which returned 4% over the past year.
Return vs Market: CLOV exceeded the US Market which returned 36% over the past year.
Price Volatility
CLOV volatility | |
---|---|
CLOV Average Weekly Movement | 16.0% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 14.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLOV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CLOV's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 552 | Andrew Toy | www.cloverhealth.com/en/ |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Clover Health Investments, Corp. Fundamentals Summary
CLOV fundamental statistics | |
---|---|
Market cap | US$2.08b |
Earnings (TTM) | -US$120.77m |
Revenue (TTM) | US$2.09b |
1.0x
P/S Ratio-16.5x
P/E RatioIs CLOV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLOV income statement (TTM) | |
---|---|
Revenue | US$2.09b |
Cost of Revenue | US$1.77b |
Gross Profit | US$319.02m |
Other Expenses | US$439.80m |
Earnings | -US$120.77m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.24 |
Gross Margin | 15.27% |
Net Profit Margin | -5.78% |
Debt/Equity Ratio | 0% |
How did CLOV perform over the long term?
See historical performance and comparison